Table 1.
Characteristics of the patients.
| Characteristics of the patients | ||
|---|---|---|
| Group 1 standard protocol | Group 2 low-dose protocol | |
| Number | 23 | 189 |
| Sex | 10 female 13 male |
84 female 105 male |
| Age (years) | 66.74 ± 2.51 | 68.94 ± 0.80 |
| Number of patients by age: | ||
| • <40 years | 0 (0%) | 1 (0,5%) |
| • 40–50 years | 3 (13%) | 11 (5,8%) |
| • 50–60 years | 4 (17.4%) | 28 (13.2%) |
| • 60–70 years | 5 (21.7%) | 47 (24.9%) |
| • 70–80 years | 8 (34.7%) | 68 (36%) |
| • 80–90 years | 3 (13%) | 33 (17.4%) |
| • Over 90 years | 0 (0%) | 1 (0.5%) |
| BMI (kg m−2) | 25.6 ± 5.7 | 25.1 ± 5.4 |
| Plasma cell disorder: | ||
| • Multiple myeloma | 12 (52.1%) | 85 (44.9%) |
| • Smoldering myeloma | 1 (4.3%) | 20 (10.6%) |
| • MGUS | 9 (39.1%) | 82 (43.4%) |
| • Plasmacytoma | 0 (0%) | 1 (0.5%) |
| • Plasma cell leukemia | 1 (4.3%) | 0 (0%) |
| • Other | 0 (0%) | 1 (0.5%) |